165438+1On October 25th, the Federal Communications Commission of the United States said that it had voted unanimously to adopt a new specification, which would prohibit the import or sale of certain technical products that pose security risks to the critical infrastructure of the United States. This is the latest development of the United States to upgrade its restrictions on China's science and technology for many years. This restriction began in the Trump era and was extended by the Biden administration.
Rosen Wassel, the chairman of the committee and a Democrat, said in a statement: "The Federal Communications Commission is committed to protecting the national security of the United States and ensuring that untrusted communication equipment will not be authorized for use in our country. We will continue to do this work. "
According to the new regulations, the United States will ban the sale of communication equipment made by Huawei and ZTE, and restrict the use of some video surveillance systems made in China, including Hikvision, Dahua and Hytera products, on the grounds that they pose unacceptable risks to US national security.
The FCC order applies to future equipment authorization, but the agency reserves the possibility of revoking previous authorization.
* * * and Carl, a member of the party's communication Committee, said on Twitter: "Because of our order, we can't approve any new Huawei or ZTE equipment. Nor can they approve any new equipment of Dahua, Hikvision or Hytera unless they assure the FCC that their equipment will not be used for public safety, government facilities safety and other national security purposes. "
The United States suppressed China in the field of science and technology, but it was nerve-racking in the field of medical devices.
China is one of the major trading partners of European medical equipment and instruments, accounting for 12% of European medical equipment market exports in 20021year. However, the European Union and the United States believe that China pursues a protectionist policy in the field of medical devices, saying that China has taken various measures to support its domestic medical device industry.
As China is not a party to the Agreement on Government Procurement of the World Trade Organization, it can only hold oral discussions with China.
It is said that drugs and medical equipment will be included in the agenda of the third meeting of the Trade and Technology Committee of the US government and the European Commission in Washington on February 5th next year.
The Committee on Trade and Technology was established in June 20021. It is an initiative organization that provides a permanent platform for transatlantic cooperation to deal with key global trade, economic and technical issues. According to the draft, the United States and the European Union are concerned about "the threats brought by a series of non-market policies and practices", such as in the field of medical devices. Medical device importers report that China used to open tenders for imported products, but now it is particularly required to use domestic products.
In this regard, the European Commission said that it has been expressing its concern about market liberalization to the competent authorities in China.
According to the draft of the Trade and Technology Commission, the United States and the European Union have analyzed and exchanged relevant data, and studied the market share of American and European medical device companies in China, in order to understand the challenges faced by the impact on American and European companies.
In fact, it is useless for the United States and Europe to express their concerns again. China government has its own reasons to support the domestic medical device industry, which is mainly for the consideration of the people. Take the heart stent as an example. A heart stent would have cost 20 thousand yuan. Now, through measures such as centralized procurement and increasing production, a heart stent of the same quality has been reduced to several hundred yuan. The quality of domestic stents is not worse than that of imported stents. Then why do people still use imported heart stents with high prices?